Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. [electronic resource]
Producer: 20040504Description: 716-21 p. digitalISSN:- 0706-7437
- Acute Disease
- Adult
- Antipsychotic Agents -- administration & dosage
- Basal Ganglia Diseases -- chemically induced
- Benzodiazepines -- administration & dosage
- Brief Psychiatric Rating Scale
- Double-Blind Method
- Drug Administration Schedule
- Female
- Haloperidol -- administration & dosage
- Humans
- Injections, Intramuscular
- Male
- Olanzapine
- Schizophrenia -- diagnosis
- Severity of Illness Index
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.